Clinical trial NCT06245187: Get With the Guidelines Atrial Fibrillation Registry
Official title: Get With the Guidelines-Atrial Fibrillation
Study type: OBSERVATIONAL
Overall status: RECRUITING
Conditions: Atrial Fibrillation
Atrial Flutter
Lead sponsor: American Heart Association
Sponsor class: OTHER
First posted: 2024-02-07
Enrollment: 17198
Sex: ALL
Minimum age (years): 18
Maximum age (years): 125
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Observational model: COHORT
Time perspective: OTHER
Sampling method: PROBABILITY_SAMPLE
Study population: The study population is patients with the diagnosis of nonvalvular Atrial Fibrillation or Atrial Flutter.

Brief summary: Get With The Guidelines-Atrial Fibrillation is designed to assist hospital care teams in consistently providing the latest evidence-based treatment for their AFib patients. At the same time, it offers a means of monitoring the quality of AFib care in U.S. hospitals and building a database for continued research and further quality improvement.

Detailed description: Get With The Guidelines-Atrial Fibrillation was initiated in 2013 with over 88 U.S. hospitals participating is designed to assist hospital care teams in consistently providing the latest evidence-based treatment for their AFib patients. At the same time, it offers a means of monitoring the quality of AFib care in U.S. hospitals and building a database for continued research and further quality improvement.

Achievement measures tracked through Get With The Guidelines-Atrial Fibrillation:

1. ACEI/ARB at discharge for LVSD
2. Assessment of thromboembolic risk factors
3. Beta Blocker at discharge
4. Discharged on FDA-approved anticoagulation therapy
5. PT/INR planned follow-up
6. Statin at discharge in AF patients with CAD, CVA/TIA or PVD.

Quality measures tracked through Get With The Guidelines-Atrial Fibrillation:

1. Aldosterone antagonist at discharge
2. Atrial fibrillation patient education
3. Anticoagulation therapy education
4. CHA2DS2-VASC reported
5. Discharge heart rate \<110bpm
6. Smoking cessation
7. Warfarin at discharge for valvular atrial fibrillation

Additional measures collected by Get With The Guidelines-Atrial Fibrillation can be viewed at: http://www.heart.org/idc/groups/heart-public/@private/@wcm/@hcm/@gwtg/documents/downloadable/ucm_451183.pdf

Eligibility criteria: Inclusion Criteria:

* Patients hospitalized with nonvalvular Atrial Fibrillation or Atrial Flutter

Exclusion Criteria:

* Patients who do not have nonvalvular Atrial Fibrillation or Atrial Flutter
* Patients under 18 years of age
* Patients not admitted as inpatients.
* Patients on comfort care only
* Patients discharged to hospice.

Primary outcomes:
measure: Cardiac Tamponade and/or Pericardiocentesis Following Ablation
timeFrame: 30 days
Secondary outcomes:
Other outcomes:
Locations:
city: Dallas
country: United States
facility: Amy Bennett
state: Texas
Study officials:
affiliation: American Heart Association
name: Javed Butler, MD
role: PRINCIPAL_INVESTIGATOR
References:
citation: January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014 Dec 2;64(21):e1-76. doi: 10.1016/j.jacc.2014.03.022. Epub 2014 Mar 28. No abstract available.